CXCL10 Blockade Protects Mice from Cystitis Induced by Cyclophosphamide
Author Information
Author(s): Sakthivel Senthilkumar K, Singh Udai P, Singh Shailesh, Taub Dennis D, Novakovic Kristian R, Lillard James W Jr
Primary Institution: Emory University School of Medicine
Hypothesis
Does CXCL10 blockade reduce the severity of cyclophosphamide-induced cystitis in mice?
Conclusion
Blocking CXCL10 in mice reduced the severity of cystitis caused by cyclophosphamide.
Supporting Evidence
- CXCL10 blockade significantly reduced the severity of cystitis in mice.
- Serum levels of CXCL9 and CXCL10 were higher in interstitial cystitis patients compared to healthy donors.
- The study suggests that CXCL10 may be a new target for treating cystitis.
Takeaway
This study found that a special treatment can help mice feel better when they have a painful bladder condition caused by a medicine.
Methodology
The study involved treating mice with cyclophosphamide and measuring the effects of anti-CXCL10 antibodies on cystitis severity.
Limitations
The study was conducted in mice, which may not fully replicate human interstitial cystitis.
Participant Demographics
32 untreated female patients with chronic interstitial cystitis and 16 healthy female donors.
Statistical Information
P-Value
p<0.001 for CXCL9, p<0.01 for CXCL10
Statistical Significance
p<0.01
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website